Statement Of Cash Flows [Abstract]

ChemoMetec - Filing #1366642

Concept	As at 2023-06-30	2022-07-01 to 2023-06-30	As at 2022-07-01	2021-07-01 to 2022-06-30	As at 2022-06-30	As at 2021-07-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	—	1,093 DKK	—	1,518 DKK	—	—
Interest received, classified as operating activities	—	2,457 DKK	—	9,000 DKK	—	—
Income taxes paid (refund), classified as operating activities	—	57,749 DKK	—	27,634 DKK	—	—
Cash flows from (used in) operating activities	—	154,146 DKK	—	176,860 DKK	—	—
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities	—	- DKK	—	- DKK	—	—
Purchase of property, plant and equipment, classified as investing activities	—	21,181 DKK	—	39,101 DKK	—	—
Purchase of intangible assets, classified as investing activities	—	19,635 DKK	—	16,815 DKK	—	—
Cash flows from (used in) investing activities	—	40,831 DKK	—	56,046 DKK	—	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	—	14,000 DKK	—	433,000 DKK	—	—
Payments of lease liabilities, classified as financing activities	—	2,844 DKK	—	1,729 DKK	—	—
Dividends paid, classified as financing activities	—	- DKK	—	69,610 DKK	—	—
Other inflows (outflows) of cash, classified as financing activities	—	67,000 DKK	—	1,895 DKK	—	—
Cash flows from (used in) financing activities	—	2,925 DKK	—	69,012 DKK	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	110,390 DKK	—	51,802 DKK	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	2,844 DKK	—	7,114 DKK	—	—
Cash and cash equivalents	316,571 DKK	—	209,025 DKK	—	209,025 DKK	150,109 DKK